Immune infiltration in pancreatic cancer correlates with high COL10A1 expression levels, with a new TUG1/miR-144-3p/COL10A1 axis identified upstream of the non-coding RNA pathway [97]. Here, COL10A1 is linked to pancreatic neoplasm.